Palvella Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$113.10

+0.47 (+0.42%)

As of Jun 21, 10:13 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 22 96%

Hold 1 4%

Sell 0 0%

Price Target

Analyst Price Target -53.3% upside

Low Target $42.56

Average Target $52.81

High Target $76.13

Current Price $113.10

Current
$113.10

Target
$52.81

$42.56 $52.81 avg $76.13

Scenario Analysis

Bear Case

$42.56

-62.4%

Low target

Base Case

$52.81

-53.3%

Avg target

Bull Case

$76.13

+-32.7%

High target

Risk/Reward

0.5x

Unfavorable

Price in Context

52-Week High

$151.18

-25.2% from high

52-Week Low

$20.20

+459.9% from low

Target vs 52W High

$52.81

-65.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.7%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+189.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-7.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.0%